No evidence seen for loss of treatment effect with discontinuation of multifocal contacts in older teenagers with myopia
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 21, 2025 (HealthDay News) — No evidence is seen for loss of treatment effect after discontinuing soft multifocal contact lenses in older teenagers with myopia, according to a study published online Jan. 16 in JAMA Ophthalmology.
David A. Berntsen, O.D., Ph.D., from the University of Houston College of Optometry, and colleagues examined whether there is a loss of treatment effect (rebound) after discontinuing soft multifocal contact lenses in the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study involving 248 children (aged 11 to 17 years at baseline) with myopia who completed the BLINK randomized clinical trial. All children in the BLINK2 study wore high-add (+2.50 diopter [D]) multifocal soft contact lenses for two years and single-vision soft contact lenses during the third year to ascertain whether rebound occurred.
The researchers found that the mean axial length and spherical equivalent refractive error were 25.2 mm and −3.40 D, respectively, at baseline. Regardless of the original BLINK treatment assignment, axial elongation increased by 0.03 mm/year after participants switched from multifocal to single-vision contact lenses, and myopia progression increased by −0.17 D per year after switching to single-vision contact lenses. Throughout BLINK2, there continued to be a difference in axial length and refractive error based on the BLINK Study treatment assignment; shorter eyes and less myopia were seen in the original high-add group than in the original medium-add (+1.50 D) and single-vision groups.
These results “support fitting children with multifocal contact lenses for myopia control at a younger age and, when possible, continuing treatment until the late teenage years when myopia progression has naturally slowed,” the authors write.
Several authors disclosed ties to the ophthalmic industry.
Editorial (subscription or payment may be required)
Copyright © 2025 HealthDay. All rights reserved.
